The main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII.
Saved in:
| Title: | The main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII. |
|---|---|
| Authors: | Pagotto, Anna1,2 (AUTHOR), Uliana, Federico3,4 (AUTHOR), Cavedon, Elena1 (AUTHOR), Nordio, Giulia1 (AUTHOR), Pierangelini, Andrea1 (AUTHOR), Acquasaliente, Laura1 (AUTHOR), Macchia, Maria Ludovica5 (AUTHOR), Bellanda, Massimo5 (AUTHOR), Gatto, Barbara1 (AUTHOR), De Silvestro, Giustina6 (AUTHOR), Marson, Piero6 (AUTHOR), Gregori, Dario7 (AUTHOR), Simioni, Paolo8 (AUTHOR), Picotti, Paola2 (AUTHOR), De Filippis, Vincenzo1 (AUTHOR) vincenzo.defilippis@unipd.it |
| Source: | Communications Biology. 8/1/2025, Vol. 8 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23993642 |
|---|---|
| DOI: | 10.1038/s42003-025-08570-2 |